To summarize, in this study, we found that CF can alleviate the toxic effects of xylene in vivo and in vitro. Our findings provided new evidence, which suggested that CF protects HSPCs from the toxic effects of xylene by inhibiting mitochondrial metabolism in monocytes and neutrophil progenitor subcluster at the single-cell resolution. This evidence concerns the gene CFTR and cystic fibrosis.